InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Gabay Avraham. Insider active across 2 companies, notably Oramed Pharmaceuticals INC.. Aggregated, 8 filings have been published. Activity tracked since 11 February 2025. The latest transaction was disclosed on 20 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Gabay Avraham is Chief Financial Officer at Oramed Pharmaceuticals INC. (XNAS). He has 7 filings in total, and in the sampled recent filings from 2024-06-21 to 2026-03-18, the buy and sell amounts are 0 EUR each, with the transaction nature indicated as Attribution.